Evidence map›Paper›PMID 35317387›Full record

ArticleFrontiers in cell and developmental biology2022

A Novel Tissue Atlas and Online Tool for the Interrogation of Small RNA Expression in Human Tissues and Biofluids.

Eric Alsop, Bessie Meechoovet, Robert Kitchen, Thadryan Sweeney, Thomas G Beach, Geidy E Serrano, Elizabeth Hutchins, Ionita Ghiran, Rebecca Reiman, Michael Syring and 15 more

Abstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Eric AlsopNeurogenomics Division, The Translational Genomics Research Institute, Phoenix, AZ, United States.
Bessie MeechoovetNeurogenomics Division, The Translational Genomics Research Institute, Phoenix, AZ, United States.
Robert KitchenCardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.
Thadryan SweeneyCardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.
Thomas G BeachBanner Sun Health Research Institute, Sun City, AZ, United States.
Geidy E SerranoBanner Sun Health Research Institute, Sun City, AZ, United States.
Elizabeth HutchinsNeurogenomics Division, The Translational Genomics Research Institute, Phoenix, AZ, United States.
Ionita GhiranDepartment of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, United States.
Rebecca ReimanNeurogenomics Division, The Translational Genomics Research Institute, Phoenix, AZ, United States.
Michael SyringNeurogenomics Division, The Translational Genomics Research Institute, Phoenix, AZ, United States.
Michael HsiehNeurogenomics Division, The Translational Genomics Research Institute, Phoenix, AZ, United States.
Amanda Courtright-LimNeurogenomics Division, The Translational Genomics Research Institute, Phoenix, AZ, United States.
Nedyalka ValkovCardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.
Timothy G WhitsettNeurogenomics Division, The Translational Genomics Research Institute, Phoenix, AZ, United States.
Jorge RakelaMayo Clinic, Scottsdale, AZ, United States.
Paul PockrosDivision of Gastroenterology/Hepatology, Scripps Clinic, La Jolla, CA, United States.
Joel RozowskyDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, United States.
Juan GallegoInstitute for Behavioral Science, The Feinstein Institute for Medical Research, Manhasset, NY, United States.
Matthew J HuentelmanNeurogenomics Division, The Translational Genomics Research Institute, Phoenix, AZ, United States.
Ravi ShahCardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.
Peter NakajiDepartment of Neurosurgery, Banner Health, Phoenix, AZ, United States.
M Yashar S KalaniDepartment of Neurosurgery, St. John Medical Center, Tulsa, OK, United States.
Louise LaurentDepartment of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Diego, San Diego, CA, United States.
Saumya DasCardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.
Kendall Van Keuren-JensenNeurogenomics Division, The Translational Genomics Research Institute, Phoenix, AZ, United States.

Funding

Research Education ComponentP30AG019610 · NIA · SUN HEALTH RESEARCH INSTITUTE · PI REIMAN, ERIC MICHAEL · 2001 to 2020
$32.5M
Research Education ComponentP30AG072980 · NIA · BANNER HEALTH · PI Nicholas Ashton · 2021 to 2026
$24.9M
Functional role and therapeutic targeting of exosomes and extracellular RNA biomarkers in heart failureR35HL150807 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI Saumya Das · 2020 to 2026
$6.7M
Scientific Outreach ComponentU54DA049098 · NIDA · BAYLOR COLLEGE OF MEDICINE · PI MILOSAVLJEVIC, ALEKSANDAR · 2019 to 2022
$5.0M
exRNA signatures Predict Outcomes after brain injuryUH3TR000891 · NCATS · TRANSLATIONAL GENOMICS RESEARCH INST · PI ADELSON, P. DAVID, HUENTELMAN, MATT · 2015 to 2017
$3.0M
Molecular dissection and imaging of extracellular vesicles to define their origin and targetsUH3TR002878 · NCATS · MASSACHUSETTS GENERAL HOSPITAL · PI DAS, SAUMYA, TALISMAN, TIJANA · 2021 to 2022
$2.2M
P.R.I.S.M: Purification of exRNA by Immuno-capture and Sorting using MicrofluidicUH3CA241703 · NCI · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI MATEESCU, BOGDAN, RAFFAI, ROBERT · 2021 to 2022
$1.4M
Optimization and Normalization Studies for CSF as a BiomarkerUH2TR000891 · NCATS · TRANSLATIONAL GENOMICS RESEARCH INST · PI ADELSON, P. DAVID, HUENTELMAN, MATT · 2013 to 2014
$1.1M
Molecular dissection and imaging of extracellular vesicles to define their origin and targetsUG3TR002878 · NCATS · MASSACHUSETTS GENERAL HOSPITAL · PI DAS, SAUMYA, TALISMAN, TIJANA · 2019 to 2020
$939k
BLRD VA IK6 BX005692NCATS NIH HHS UG3 TR002878NCATS NIH HHS UH2 TR000891NCATS NIH HHS UH3 TR000891NCATS NIH HHS UH3 TR002878NCI NIH HHS UH3 CA241703NHLBI NIH HHS R35 HL150807NIA NIH HHS P30 AG019610NIA NIH HHS P30 AG072980NIDA NIH HHS U54 DA049098
6 · The paper itself

Abstract

One promising goal for utilizing the molecular information circulating in biofluids is the discovery of clinically useful biomarkers. Extracellular RNAs (exRNAs) are one of the most diverse classes of molecular cargo, easily assayed by sequencing and with expressions that rapidly change in response to subject status. Despite diverse exRNA cargo, most evaluations from biofluids have focused on small RNA sequencing and analysis, specifically on microRNAs (miRNAs). Another goal of characterizing circulating molecular information, is to correlate expression to injuries associated with specific tissues of origin. Biomarker candidates are often described as being specific, enriched in a particular tissue or associated with a disease process. Likewise, miRNA data is often reported to be specific, enriched for a tissue, without rigorous testing to support the claim. Here we provide a tissue atlas of small RNAs from 30 different tissues and three different blood cell types. We analyzed the tissues for enrichment of small RNA sequences and assessed their expression in biofluids: plasma, cerebrospinal fluid, urine, and saliva. We employed published data sets representing physiological (resting vs. acute exercise) and pathologic states (early- vs. late-stage liver fibrosis, and differential subtypes of stroke) to determine differential tissue-enriched small RNAs. We also developed an online tool that provides information about exRNA sequences found in different biofluids and tissues. The data can be used to better understand the various types of small RNA sequences in different tissues as well as their potential release into biofluids, which should help in the validation or design of biomarker studies.

Indexed as

cerebrospinal fluidextracellular RNAextracellular vesicleplasmasalivasmall RNAtissue atlasurine

Identifiers

PMID35317387
PMCPMC8934391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.